Pharmaceutical Market Access and Drug Safety Act of 2007
Latest action · Mar 7, 2007 Committee on Commerce, Science, and Transportation Subcommittee on Interstate Commerce, Trade, and Tourism. Hearings held. With printed Hearing: S.Hrg. 110-1189.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 10, 2007
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.
Cosponsors 36
Members who signed on, in the order they did. Signatures ran from Jan 10, 2007 to Jul 15, 2008; 28 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-PA | Arlen Specter | Original | Jan 10, 2007 |
| D-IL | Barack Obama | Original | Jan 10, 2007 |
| D-CA | Barbara Boxer | Original | Jan 10, 2007 |
| I-VT | Bernard Sanders | Original | Jan 10, 2007 |
| D-FL | Bill Nelson | Original | Jan 10, 2007 |
| D-AR | Blanche L. Lincoln | Original | Jan 10, 2007 |
| D-MI | Carl Levin | Original | Jan 10, 2007 |
| D-NY | Charles E. Schumer | Original | Jan 10, 2007 |
| R-IA | Chuck Grassley | Original | Jan 10, 2007 |
| D-HI | Daniel K. Inouye | Original | Jan 10, 2007 |
| D-MI | Debbie Stabenow | Original | Jan 10, 2007 |
| D-CA | Dianne Feinstein | Original | Jan 10, 2007 |
| D-MA | Edward M. Kennedy | Original | Jan 10, 2007 |
| D-WI | Herb Kohl | Original | Jan 10, 2007 |
| D-NY | Hillary Rodham Clinton | Original | Jan 10, 2007 |
| D-NM | Jeff Bingaman | Original | Jan 10, 2007 |
| D-MA | John F. Kerry | Original | Jan 10, 2007 |
| R-AZ | John McCain | Original | Jan 10, 2007 |
| D-MT | Jon Tester | Original | Jan 10, 2007 |
| D-CO | Ken Salazar | Original | Jan 10, 2007 |
| D-AR | Mark L. Pryor | Original | Jan 10, 2007 |
| R-ME | Olympia J. Snowe | Original | Jan 10, 2007 |
| D-VT | Patrick J. Leahy | Original | Jan 10, 2007 |
| D-IL | Richard J. Durbin | Original | Jan 10, 2007 |
| D-OR | Ron Wyden | Original | Jan 10, 2007 |
| D-WI | Russell D. Feingold | Original | Jan 10, 2007 |
| D-OH | Sherrod Brown | Original | Jan 10, 2007 |
| R-ME | Susan M. Collins | Original | Jan 10, 2007 |
| D-PA | Robert P. Casey Jr. | Jan 22, 2007 | |
| D-ND | Kent Conrad | Feb 26, 2007 | |
| D-SD | Tim Johnson | Feb 27, 2007 | |
| D-MO | Claire McCaskill | May 1, 2007 | |
| D-VA | Jim Webb | May 7, 2007 | |
| R-SD | John Thune | Jun 11, 2007 | |
| D-RI | Sheldon Whitehouse | Jun 12, 2007 | |
| D-MN | Amy Klobuchar | Jul 15, 2008 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Jan 10, 2007 |
| Senate | Commerce, Science, and Transportation Committee | |
| Interstate Commerce, Trade, and Tourism Subcommittee | Hearings Mar 7, 2007 |
Actions 4
Everything that happened, newest first.
- Mar 7, 2007Committee on Commerce, Science, and Transportation Subcommittee on Interstate Commerce, Trade, and Tourism. Hearings held. With printed Hearing: S.Hrg. 110-1189.
- Jan 10, 2007Introduced in Senate
- Jan 10, 2007Sponsor introductory remarks on measure. (CR S384-385)
- Jan 10, 2007Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S384 | Byron L. Dorgan D-ND | Jan 10, 2007 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 4
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 110-213 | MISCELLANEOUS NATIONAL PARKS LEGISLATION74 pages | Energy and Natural Resources Committee | Sep 11, 2007 |
| Serial No. 110-33 | THE 2007 MEDICARE TRUSTEES REPORT56 pages | Ways and Means Committee | Apr 25, 2007 |
| Serial No. 110-32 | MEMBER PROPOSALS ON ENERGY TAX INCENTIVES79 pages | Ways and Means Committee | Apr 24, 2007 |
| S. Hrg. 110-1189 | POLICY IMPLICATIONS OF PHARMACEUTICAL IMPORTATION FOR U.S. CONSUMERS115 pages | Commerce, Science, and Transportation Committee | Mar 7, 2007 |
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| RS22660 | Prescription Drug Importation: How S. 1232 (S. 525/H.R. 1298) Would Change Current Law Archived | Report | Jun 16, 2009 |
| RL32511 | Importing Prescription Drugs: Objectives, Options, and Outlook Archived | Report | Jan 26, 2007 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 380 | Pharmaceutical Market Access and Drug Safety Act of 2007 | Identical bill | Feb 2, 2007 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
- Short Titles as Introduced
- Pharmaceutical Market Access and Drug Safety Act of 2007
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Accreditation (Medical care)
- Administrative fees
- Administrative procedure
- Administrative remedies
- Australia
- Business records
- Canada
- Checks
- Civil actions and liability
- Civil Rights and Liberties, Minority Issues
- Commerce
- Congress
- Congressional reporting requirements
- Consumer education
- Contracts
- Credit cards
- Crime and Law Enforcement
- Customs administration
- Damages
- Defective products
- Department of Health and Human Services
- Directories
- Drug advertising
- Drug approvals
- Drug industry
- Drugs
- East Asia
- Economics and Public Finance
- Education
- Electronic commerce
- Electronic data interchange
- Electronic funds transfers
- Electronic government information
- Europe
- European Union
- Evidence (Law)
- Export controls
- Exports
- Federal preemption
- Federal Trade Commission
- Federal-state relations
- Finance and Financial Sector
- Fines (Penalties)
- Food and Drug Administration (FDA)
- Foreign Trade and International Finance
- Forfeiture
- Fraud
- Government Operations and Politics
- Government paperwork
- Government publicity
- Governmental investigations
- Health
- Higher education
- Identification devices
- Import restrictions
- Imports
- Independent regulatory commissions
- Injunctions
- Intellectual property
- Interactive media
- Internet
- Japan
- Labeling
- Law
- Liability (Law)
- Licenses
- Medical associations
- Medical education
- Medical records
- Medical tests
- New Zealand
- Oceania
- Packaging
- Parties to actions
- Patent infringement
- Patents
- Pharmaceutical research
- Pharmacies
- Pharmacists
- Physical examinations
- Prescription pricing
- Price discrimination
- Product counterfeiting
- Restrictive trade practices
- Right of privacy
- Science, Technology, Communications
- State laws
- Surety and fidelity
- Switzerland
- Telephone
- User charges
- Web sites
- Wholesale trade
Text 1
Each version as it was printed, newest first.
- Jan 10, 2007Introduced in Senate
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.